Advancing Cardiovascular Risk Assessment with Accuracy and Flexibility
The Diazyme Lipoprotein (a) Assay is a liquid-stable, dual-vial immunoturbidimetric test for quantitative Lp(a) measurement in human serum or plasma. It delivers precise results in under 10 minutes and integrates easily with routine clinical chemistry analyzers, supporting comprehensive cardiovascular risk evaluation.
FDA Cleared & CE Marked
Trusted performance and regulatory confidence for clinical laboratories.
Fast, Reliable Results
Delivers precise results in under 10 minutes with minimal hands-on time.
Supports Early Risk Identification
Supports identification of CHD, stroke, and restenosis risks.
Liquid-Stable Reagents
Ready-to-use reagents designed for efficient laboratory workflows.
Why Measure Lp(a)?
Elevated Lp(a) is an independent cardiovascular risk factor associated with coronary heart disease and stroke. Measuring Lp(a) helps identify at-risk patients earlier and supports more informed clinical decisions.
Independent Risk Factor
Helps evaluate Lp(a) as an independent cardiovascular risk factor.
Supports Earlier Identification
Helps identify patients who may benefit from earlier cardiovascular risk management.
Supports Risk Assessment
Supports comprehensive cardiovascular risk assessment.
Complete the form to access technical details and assay information.
* Required field